Galena Biopharma (GALE) Misses Q1 Loss Views

Galena Biopharma (NASDAQ: GALE) reported Q1 EPS of ($0.52), $0.42 worse than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Galena Biopharma (GALE) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Deere shares climb as fiscal Q3 earnings and revenue top estimates
• 'We expect salesforce.com (CRM) to capture a meaningful share of next-gen agentic workflows': Cantor